Opportunity Information: Apply for CDC RFA CE09 9010301SUPP12
Apply for CDC RFA CE09 9010301SUPP12
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Domestic Violence Prevention Enhancement and Leadership Through Alliance (DELTA) III Program" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.136 Injury Prevention and Control Research and State and Community Based Programs.
- This funding opportunity was created on Dec 27, 2011 and posted on Dec 27, 2011.
- Applicants must submit their applications by Jan 17, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $420,000.00 in funding.
- The number of recipients for this funding is limited to 14 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- CE09 901 Grantees
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Domestic Violence Prevention Enhancement and Leadership Through Alliance (DELTA) III Program supplemental funding opportunity (CDC RFA CE09 9010301SUPP12) is a Centers for Disease Control and Prevention (CDC) cooperative agreement designed to provide a single additional year of funding to organizations already funded under the earlier DELTA III award (CE09-901). The intent is not to launch new projects or bring in new recipients, but to keep current grantees operating at their existing funding levels long enough to finish key work that was already underway. In practical terms, this supplement functions as a continuation bridge so the original DELTA III investments can be completed in a way that is usable, defensible, and shareable across the intimate partner violence (IPV) prevention field.
The focus of the supplemental year is on strengthening and completing four core areas of DELTA III work: capacity building, implementation, evaluation, and sustainability. Capacity building generally refers to improving the skills, structures, partnerships, and internal systems that allow a grantee and its partners to carry out IPV prevention effectively over time. Implementation refers to putting prevention strategies into action in real settings, including coordinating partners, delivering or supporting interventions, and addressing barriers that come up in the field. Evaluation emphasizes documenting what was done, how well it was delivered, and what outcomes or lessons emerged, so stakeholders can understand effectiveness and make informed decisions. Sustainability is about ensuring the work does not end when a grant ends, such as by embedding prevention approaches into organizational practices, policies, community partnerships, and longer-term funding or infrastructure.
A major reason this supplemental funding is described as critical is that it supports the final refinement and completion of the above components and helps ensure results are communicated beyond the immediate grant team. The FOA specifically highlights sharing results with stakeholders in the IPV field, which typically means packaging findings, tools, approaches, and lessons learned in ways that other programs, coalitions, and decision-makers can use. This can include dissemination of evaluation results, descriptions of implementation models, and materials that help others replicate or adapt successful approaches.
Administratively, the opportunity is offered under a cooperative agreement mechanism, which signals substantial federal involvement compared to a standard grant. While the FOA text provided does not detail the exact roles, cooperative agreements commonly involve CDC engagement in areas like technical assistance, performance monitoring, or collaboration on evaluation and dissemination expectations. The activity category is health, and the program aligns with CFDA 93.136 (Injury Prevention and Control Research and State and Community Based Programs), reflecting CDC's IPV prevention framing as a public health and injury prevention priority.
The CDC anticipated making 14 awards under this supplemental announcement. Funding levels were set with an award ceiling of $420,000 and an award floor of $170,000, and the FOA indicates the funds are provided at current levels, implying that each grantee's supplement amount would align with what they were already receiving rather than introducing a new competitive tier structure. There is no cost sharing or matching requirement, so recipients are not required to contribute non-federal funds as a condition of receiving the award.
Eligibility is narrowly limited to existing CE09-901 grantees. The listing of "EligibleApplicants: Others" is clarified by the eligibility note stating that only CE09-901 grantees may apply, meaning new applicants outside the current DELTA III cohort are not eligible for this supplement. This structure reinforces that the purpose is completion and dissemination of ongoing work rather than expansion to new jurisdictions or organizations.
Key dates show the opportunity was posted and created on December 27, 2011, with an original and current closing date of January 17, 2012, and an archive date of February 16, 2012. Interested eligible recipients who had trouble accessing the full announcement were directed to contact the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), via phone at 770-488-2700, with reference to general email submissions noted in the contact section.
Overall, this DELTA III supplemental FOA is best understood as a targeted, time-limited continuation award meant to help existing grantees finish the harder end-stage work that often determines whether prevention efforts leave behind lasting infrastructure and credible evidence. By emphasizing refinement, evaluation completion, sustainability planning, and stakeholder communication, CDC is signaling that the value of the DELTA III portfolio depends not only on delivering activities, but on documenting results and ensuring that effective prevention approaches can persist and inform the broader IPV prevention community.
Frequently Asked Questions (FAQs) - DELTA III Supplemental Funding (CDC RFA CE09 9010301SUPP12)
What is the DELTA III Program supplemental funding opportunity?
The Domestic Violence Prevention Enhancement and Leadership Through Alliance (DELTA) III supplemental funding opportunity (CDC RFA CE09 9010301SUPP12) is a CDC cooperative agreement that provides one additional year of funding to organizations that were already funded under the earlier DELTA III award (CE09-901).
Is this opportunity open to new applicants?
No. Eligibility is narrowly limited to current CE09-901 grantees. The supplement is intended to support existing recipients, not to bring in new organizations or start new projects.
What is the purpose of offering a supplemental year of funding?
The supplement functions as a continuation bridge so existing DELTA III grantees can maintain their current funding levels long enough to complete key work that was already underway, especially end-stage tasks that support usable, defensible, and shareable results for the intimate partner violence (IPV) prevention field.
Does this supplement fund new projects or expansions?
No. The intent is not to launch new projects or expand to new recipients or jurisdictions. It is designed to keep current grantees operating at their existing funding levels to finish ongoing work.
What are the main focus areas for the supplemental year?
The supplemental year emphasizes strengthening and completing four core areas of DELTA III work: capacity building, implementation, evaluation, and sustainability.
What does "capacity building" mean in this FOA?
Capacity building refers to improving skills, structures, partnerships, and internal systems that enable a grantee and its partners to carry out IPV prevention effectively over time.
What does "implementation" mean in this FOA?
Implementation refers to putting prevention strategies into action in real-world settings, including coordinating partners, delivering or supporting interventions, and addressing barriers that arise in the field.
What does "evaluation" mean in this FOA?
Evaluation emphasizes documenting what was done, how well it was delivered, and what outcomes or lessons emerged so stakeholders can understand effectiveness and make informed decisions.
What does "sustainability" mean in this FOA?
Sustainability focuses on ensuring the work continues beyond the grant period, such as embedding prevention approaches into organizational practices, policies, partnerships, and longer-term funding or infrastructure.
Why does the FOA emphasize sharing results with stakeholders?
The FOA highlights communicating results beyond the immediate grant team so findings, tools, approaches, and lessons learned can be packaged in ways that other programs, coalitions, and decision-makers in the IPV prevention field can use.
What kinds of dissemination or sharing activities are referenced?
Examples mentioned include disseminating evaluation results, describing implementation models, and developing materials that help others replicate or adapt successful approaches.
What is the funding mechanism for this opportunity?
The opportunity is offered as a cooperative agreement, which indicates substantial federal involvement compared to a standard grant.
What does a cooperative agreement imply about CDC involvement?
While the provided text does not specify exact roles, cooperative agreements commonly involve CDC engagement such as technical assistance, performance monitoring, or collaboration on evaluation and dissemination expectations.
How many awards did CDC anticipate making under this supplement?
CDC anticipated making 14 awards under this supplemental announcement.
What are the award floor and ceiling amounts?
The award ceiling is $420,000 and the award floor is $170,000.
Will award amounts be newly set through competition?
The FOA indicates funds are provided at current levels, implying that each eligible grantee's supplement amount would align with what they were already receiving under DELTA III rather than being determined by a new tiered structure.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement for this opportunity.
What is the program area or activity category?
The activity category is health, and the program is framed within intimate partner violence prevention as a public health and injury prevention priority.
What CFDA number is associated with this opportunity?
The opportunity aligns with CFDA 93.136 (Injury Prevention and Control Research and State and Community Based Programs).
When was the opportunity posted, and what were the closing and archive dates?
The opportunity was posted/created on December 27, 2011. The original and current closing date was January 17, 2012. The archive date was February 16, 2012.
Who should eligible applicants contact if they have trouble accessing the full announcement?
Eligible recipients who had trouble accessing the full announcement were directed to contact the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), by phone at 770-488-2700.
What is the overall goal of this supplemental FOA?
The overall goal is to provide a time-limited continuation award that helps existing grantees complete refinement, evaluation, sustainability planning, and stakeholder communication so DELTA III investments result in lasting infrastructure and credible evidence that can inform the broader IPV prevention community.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: OVC FY 12 State Victim Assistance Academy (New)
Previous opportunity: OJJDP FY 2012 National Intertribal Youth Summit
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA CE09 9010301SUPP12
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA CE09 9010301SUPP12) also looked into and applied for these:
| Funding Opportunity |
|---|
| SAVING LIVES AT BIRTH A GRAND CHALLENGE Apply for DRAFT RFA OAA 12 000006 Funding Number: DRAFT RFA OAA 12 000006 Agency: Agency for International Development Category: Health Funding Amount: $13,000,000 |
| Evaluation of Dengue Epidemiology, Outcomes, and Prevention in Sentinel Surveillance and Research Sites in Puerto Rico Apply for RFA CK 12 001 Funding Number: RFA CK 12 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Operations Research (Implementation Science) for Strengthening Program Implementation through the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for RFA GH 12 008 Funding Number: RFA GH 12 008 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Provision of Comprehensive HIV/AIDS Care, Treatment and Prevention Services in indigenous Health Facilities in the Republic of Uganda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1209 Funding Number: CDC RFA GH12 1209 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| A Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Apply for RFA DD 12 002 Funding Number: RFA DD 12 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Collaborative R34s for Pilot Studies of Innovative Treatments in Mental Disorders (Collaborative R34) Apply for PAR 12 071 Funding Number: PAR 12 071 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Clinical Trials in Organ Transplantation in Children (U01) Apply for RFA AI 12 005 Funding Number: RFA AI 12 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Identifying Reasons for Racial/Ethnic Disparities with Completing the HPV Vaccine Series among Adolescent Females Apply for RFA IP 12 004 Funding Number: RFA IP 12 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Intervention Study to Increase Use of Standing Orders Programs for Vaccinating Adults in Physician Office Settings Apply for RFA IP 12 005 Funding Number: RFA IP 12 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Affordable Care Act Maternal, Infant, and Early Childhood Home Visiting Research Network Apply for HRSA 12 158 Funding Number: HRSA 12 158 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Multidisciplinary Clinical Research Centers (P60) Apply for RFA AR 13 001 Funding Number: RFA AR 13 001 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| NINDS Exploratory Clinical Trials for Small Business (STTR R42) Apply for PAR 12 072 Funding Number: PAR 12 072 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| NINDS Exploratory Clinical Trials for Small Business (SBIR R44) Apply for PAR 12 073 Funding Number: PAR 12 073 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NINDS Competing Renewal Awards of STTR Phase II Grants (Phase IIB) for Exploratory Clinical Trials (STTR R42) Apply for PAR 12 074 Funding Number: PAR 12 074 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Competing Renewal Awards of SBIR Phase II Grants (Phase IIB) for Exploratory Clinical Trials (SBIR R44) Apply for PAR 12 075 Funding Number: PAR 12 075 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Competing Renewal Awards of SBIR Phase II (Phase IIB) Grants (SBIR R44) Apply for PAR 12 077 Funding Number: PAR 12 077 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Competing Renewal Awards of STTR Phase II (Phase IIB) Grants (STTR R42) Apply for PAR 12 076 Funding Number: PAR 12 076 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| CHILDRENS HEALTH INSURANCE PROGRAM REAUTHORIZATION ACT (CHIPRA)PROSPECTIVE PAYMENT SYSTEM (PPS) FOR FEDERALLY QUALIFIED HEALTH CENTERS (FQHCs) AND RURAL HEALTH CLINICS (RHCs) TRANSITION GRANTS SECOND RELEASE Apply for CMS 1Z0 12 001 Funding Number: CMS 1Z0 12 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $500,000 |
| Molecular Characterization of Salivary Gland Tumors (R21) Apply for RFA DE 12 012 Funding Number: RFA DE 12 012 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Molecular Characterization of Salivary Gland Tumors (R01) Apply for RFA DE 12 011 Funding Number: RFA DE 12 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA CE09 9010301SUPP12", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.